GlassScriptPhysician profile
Jonathan V Norton
NPI 1609879683
$4,444.17
in general payments reported to CMS, 2019-2025
24 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,895 · 2020: $1,535 · 2022: $97.94 · 2023: $125 · 2024: $407 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $3,000.00 | 2019-2020 | |
| Organogenesis INC. | $202.25 | 2019 | |
| Kerecis Limited | $191.93 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $166.32 | 2024-2025 | Collagenase Santyl, Renasys, Q-Fix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.95 | 2024 | Jardiance |
| Stryker Corporation | $103.73 | 2019 | |
| Treace Medical Concepts, INC. | $68.64 | 2023-2024 | |
| Paragon 28, INC. | $60.16 | 2019-2024 | Monkey Rings |
| Integra Lifesciences Corporation | $56.67 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Encore Medical, LP | $54.50 | 2022 | |
| Globus Medical, INC. | $54.21 | 2025 | Senza |
| Ossur Americas, INC. | $50.07 | 2025 | |
| Depuy Synthes Sales INC. | $42.79 | 2023 | Hammerlock |
| Baxter Healthcare | $37.14 | 2025 | Perclot |
| Mimedx Group, INC. | $34.99 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $34.69 | 2022-2023 | Nuzyra |
| Ortho Solutions INC | $33.70 | 2023 | |
| Linvatec Corporation | $27.42 | 2024 | Biobrace 23mm |
| Allergan, INC. | $26.53 | 2020 | |
| Orthofix Medical, INC. | $22.28 | 2019 | |
| Abbvie INC. | $21.47 | 2022 | |
| Kci USA, INC. | $18.58 | 2023 | Activ.A.C. |
| Solventum Corporation | $14.50 | 2024 | Activ.A.C., Prevena |
| Horizon Therapeutics Plc | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Norton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.